Patent applications and USPTO patent grants for Davis; Samuel.The latest application filed is for "novel antigen binding molecule formats".
Patent | Date |
---|---|
Methods and antibody compositions for tumor treatment Grant 11,434,300 - Smith , et al. September 6, 2 | 2022-09-06 |
Novel Antigen Binding Molecule Formats App 20220235126 - Zhang; Tong ;   et al. | 2022-07-28 |
Novel Antigen Binding Molecule Formats App 20220195030 - Zhang; Tong ;   et al. | 2022-06-23 |
Readily Isolated Bispecific Antibodies with Native Immunoglobulin Format App 20220024973 - Davis; Samuel ;   et al. | 2022-01-27 |
Readily isolated bispecific antibodies with native immunoglobulin format Grant 11,168,111 - Davis , et al. November 9, 2 | 2021-11-09 |
Il-2 Variants With Reduced Binding To Il-2 Receptor Alpha And Uses Thereof App 20210324030 - Wu; Jiaxi ;   et al. | 2021-10-21 |
Glucagon-like Peptide 1 Receptor Agonists And Uses Thereof App 20210283225 - Wei; Yang ;   et al. | 2021-09-16 |
Antibodies Comprising Chimeric Constant Domains App 20210246207 - Davis; Samuel ;   et al. | 2021-08-12 |
Glucagon-like peptide 1 receptor agonists and uses thereof Grant 11,045,522 - Wei , et al. June 29, 2 | 2021-06-29 |
Methods of modifying genes in eukaryotic cells Grant 10,988,776 - Economides , et al. April 27, 2 | 2021-04-27 |
Antibodies comprising chimeric constant domains Grant 10,988,537 - Davis , et al. April 27, 2 | 2021-04-27 |
Novel Antigen Binding Molecule Formats App 20210040197 - Zhang; Tong ;   et al. | 2021-02-11 |
Multivalent Antigen-Binding Proteins App 20200299414 - Yancopoulos; George D. ;   et al. | 2020-09-24 |
Methods for tumor treatment using CD3XCD20 bispecific antibody Grant 10,662,244 - Smith , et al. | 2020-05-26 |
Methods and Antibody Compositions for Tumor Treatment App 20200115464 - Smith; Eric ;   et al. | 2020-04-16 |
Heavy Chain Constant Regions with Reduced Binding to Fc Gamma Receptors App 20200109203 - Davis; Samuel ;   et al. | 2020-04-09 |
Use of angiopoietins in promoting blood coagulation and in the treatment of blood coagulation disorders Grant 10,588,940 - Daly , et al. | 2020-03-17 |
Heavy chain constant regions with reduced binding to Fc gamma receptors Grant 10,556,952 - Davis , et al. Feb | 2020-02-11 |
Systems And Methods For Enhancing And Refining Knowledge Representations Of Large Document Corpora App 20200042580 - DAVIS; Samuel ;   et al. | 2020-02-06 |
Methods and antibody compositions for tumor treatment Grant 10,550,193 - Smith , et al. Fe | 2020-02-04 |
Methods of making nucleic acid molecules encoding modified chimeric polypeptides with improved pharmacokinetic properties Grant 10,392,430 - Papadopoulos , et al. A | 2019-08-27 |
Common Light Chain Mouse App 20190090462 - Babb; Robert ;   et al. | 2019-03-28 |
Glucagon-Like Peptide 1 Receptor Agonists and Uses Thereof App 20190091296 - Wei; Yang ;   et al. | 2019-03-28 |
Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain App 20190071519 - McWhirter; John ;   et al. | 2019-03-07 |
Readily Isolated Bispecific Antibodies With Native Immunoglobulin Format App 20190031713 - Davis; Samuel ;   et al. | 2019-01-31 |
Common Light Chain Mouse App 20190021295 - Babb; Robert ;   et al. | 2019-01-24 |
Methods Of Modifying Genes In Eukaryotic Cells App 20180371493 - Economides; Aris N. ;   et al. | 2018-12-27 |
Antibodies Comprising Chimeric Constant Domains App 20180371090 - Davis; Samuel ;   et al. | 2018-12-27 |
Use of Angiopoietins in Promoting Blood Coagulation and in the Treatment of Blood Coagulation Disorders App 20180318392 - DALY; Christopher ;   et al. | 2018-11-08 |
Antibodies comprising chimeric constant domains Grant 10,106,610 - Davis , et al. October 23, 2 | 2018-10-23 |
Heavy Chain Constant Regions with Reduced Binding to Fc Gamma Receptors App 20180282411 - Davis; Samuel ;   et al. | 2018-10-04 |
Methods For Tumor Treatment Using Cd3xcd20 Bispecific Antibody App 20180194841 - Smith; Eric ;   et al. | 2018-07-12 |
Readily isolated bispecific antibodies with native immunoglobulin format Grant 9,982,013 - Davis , et al. May 29, 2 | 2018-05-29 |
Modified Chimeric Polypeptides With Improved Pharmacokinetic Properties App 20180051066 - PAPADOPOULOS; Nicholas J. ;   et al. | 2018-02-22 |
Multivalent Antigen-binding Proteins App 20170260293 - YANCOPOULOS; George D. ;   et al. | 2017-09-14 |
Multivalent Antigen-binding Proteins App 20170247474 - YANCOPOULOS; George D. ;   et al. | 2017-08-31 |
Modified chimeric polypeptides with improved pharmacokinetic properties Grant 9,708,386 - Papadopoulos , et al. July 18, 2 | 2017-07-18 |
Antibodies Comprising Chimeric Constant Domains App 20160347839 - Davis; Samuel ;   et al. | 2016-12-01 |
Readily Isolated Bispecific Antibodies With Native Immunoglobulin Format App 20160251395 - Davis; Samuel ;   et al. | 2016-09-01 |
Common Light Chain Mouse App 20160219847 - MCWHIRTER; JOHN ;   et al. | 2016-08-04 |
Antibodies comprising chimeric constant domains Grant 9,359,437 - Davis , et al. June 7, 2 | 2016-06-07 |
Modified Chimeric Polypeptides With Improved Pharmacokinetic Properties App 20160130320 - PAPADOPOULOS; Nicholas J. ;   et al. | 2016-05-12 |
Readily isolated bispecific antibodies with native immunoglobulin format Grant 9,309,326 - Davis , et al. April 12, 2 | 2016-04-12 |
Common Light Chain Mouse App 20150313193 - McWhirter; John ;   et al. | 2015-11-05 |
Methods and Antibody Compositions for Tumor Treatment App 20150266966 - Smith; Eric ;   et al. | 2015-09-24 |
Mutivalent Antigen-binding Proteins App 20150203591 - Yancopoulos; George D. ;   et al. | 2015-07-23 |
Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain App 20150059009 - McWhirter; John ;   et al. | 2015-02-26 |
Readily Isolated Bispecific Antibodies With Native Immunoglobulin Format App 20140248664 - Davis; Samuel ;   et al. | 2014-09-04 |
Antibodies Comprising Chimeric Constant Domains App 20140243504 - DAVIS; Samuel ;   et al. | 2014-08-28 |
Modified Chimeric Polypeptides With Improved Pharmacokinetic Properties App 20140194597 - Papadopoulos; Nicholas J. ;   et al. | 2014-07-10 |
Methods Of Modifying Genes In Eukaryotic Cells App 20140155689 - Economides; Aris N. ;   et al. | 2014-06-05 |
Methods for producing a fusion protein capable of binding VEGF Grant 8,647,842 - Papadopoulos , et al. February 11, 2 | 2014-02-11 |
Readily isolated bispecific antibodies with native immunoglobulin format Grant 8,586,713 - Davis , et al. November 19, 2 | 2013-11-19 |
Common Light Chain Mouse App 20130302836 - McWhirter; John ;   et al. | 2013-11-14 |
Mice Expressing A Limited Immunoglobulin Light Chain Repertoire App 20130198880 - BABB; Robert ;   et al. | 2013-08-01 |
Humanized Universal Light Chain Mice App 20130198879 - McWhirter; John ;   et al. | 2013-08-01 |
Common Light Chain Mouse App 20130185821 - BABB; Robert ;   et al. | 2013-07-18 |
Methods for Producing a Fusion Protein Capable of Binding VEGF App 20130149744 - Papadopoulos; Nicholas J. ;   et al. | 2013-06-13 |
Cell Culture Compositions Capable of Producing a VEGF-Binding Fusion Polypeptide App 20130084635 - PAPADOPOULOS; Nicholas J. ;   et al. | 2013-04-04 |
Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain App 20130045492 - Babb; Robert ;   et al. | 2013-02-21 |
Cell culture compositions capable of producing a VEGF-binding fusion polypeptide Grant 8,343,737 - Papadopoulos , et al. January 1, 2 | 2013-01-01 |
Common Light Chain Mouse App 20120192300 - Babb; Robert ;   et al. | 2012-07-26 |
Cell Culture Compositions Capable of Producing a VEGF-Binding Fusion Polypeptide App 20120064621 - Papadopoulos; Nicholas J. ;   et al. | 2012-03-15 |
Common Light Chain Mouse App 20120021409 - McWhirter; John ;   et al. | 2012-01-26 |
Isolated nucleic acid molecules encoding a fusion protein capable of binding VEGF Grant 8,084,234 - Papadopoulos , et al. December 27, 2 | 2011-12-27 |
Modified chimeric polypeptides with improved pharmacokinetic properties Grant 8,029,791 - Papadopoulos , et al. October 4, 2 | 2011-10-04 |
Common Light Chain Mouse App 20110195454 - MCWHIRTER; JOHN ;   et al. | 2011-08-11 |
Nucleic acid molecule encoding a fusion polypeptide capable of binding VEGF Grant 7,964,377 - Papadopoulos , et al. June 21, 2 | 2011-06-21 |
Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties App 20110028698 - Papadopoulos; Nicholas J. ;   et al. | 2011-02-03 |
Readily Isolated Bispecific Antibodies with Native Immunoglobulin Format App 20100331527 - DAVIS; SAMUEL ;   et al. | 2010-12-30 |
Modified Chimeric Polypeptides With Improved Pharmacokinetic Properties App 20100221782 - Papadopoulos; Nicholas J. ;   et al. | 2010-09-02 |
Methods of inhibiting ascites formation with modified chimeric VEGF polypeptides Grant 7,704,500 - Papadopoulos , et al. April 27, 2 | 2010-04-27 |
Kinetic display assembly Grant 7,676,969 - Davis March 16, 2 | 2010-03-16 |
Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties App 20090155899 - Papadopoulos; Nicholas J. ;   et al. | 2009-06-18 |
Modified chimeric polypeptides with improved pharmacokinetic properties Grant 7,524,499 - Papadopoulos , et al. April 28, 2 | 2009-04-28 |
Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties App 20090081217 - Papadopoulos; Nicholas J. ;   et al. | 2009-03-26 |
Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties App 20080194799 - PAPADOPOULOS; Nicholas J. ;   et al. | 2008-08-14 |
Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties and Methods of Using Thereof App 20080194460 - PAPADOPOULOS; Nicholas J. ;   et al. | 2008-08-14 |
Modified chimeric polypeptides with improved pharmacokinetic properties Grant 7,374,757 - Papadopoulos , et al. May 20, 2 | 2008-05-20 |
Modified chimeric polypeptides with improved pharmacokinetic properties and methods of using thereof Grant 7,374,758 - Papadopoulos , et al. May 20, 2 | 2008-05-20 |
Kinetic display assembly Grant 7,356,953 - Davis April 15, 2 | 2008-04-15 |
Methods of modifying genes in eukaryotic cells App 20070275466 - Economides; Aris N. ;   et al. | 2007-11-29 |
Genome mutation by intron insertion into an embryonic stem cell genome Grant 7,205,148 - Economides , et al. April 17, 2 | 2007-04-17 |
Kinetic display assembly App 20070056197 - Davis; Samuel | 2007-03-15 |
Modified chimeric polypeptides with improved pharmacokinetic properties Grant 7,070,959 - Papadopoulos , et al. July 4, 2 | 2006-07-04 |
TIE-2 ligands, methods of making and uses thereof Grant 7,063,840 - Davis , et al. June 20, 2 | 2006-06-20 |
Nucleic acid encoding TIE-2 ligand Grant 7,063,965 - Davis , et al. June 20, 2 | 2006-06-20 |
Expressed ligand-vascular intercellular signaling molecule Grant 7,045,302 - Davis , et al. May 16, 2 | 2006-05-16 |
Method of enhancing the biological activity of ligands Grant 7,008,781 - Davis , et al. March 7, 2 | 2006-03-07 |
Modified chimeric polypeptides with improved pharmacokinetic properties and methods of making and using thereof App 20050245447 - Papadopoulos, Nicholas J. ;   et al. | 2005-11-03 |
Expressed ligand - vascular intercellular signaling molecule App 20050186665 - Davis, Samuel ;   et al. | 2005-08-25 |
Modified chimeric polypeptides with improved pharmacokinetic properties and methods of making and using thereof App 20050163798 - Papadopoulos, Nicholas J. ;   et al. | 2005-07-28 |
Expressed ligand-vascular intercellular signaling molecule App 20050106099 - Davis, Samuel ;   et al. | 2005-05-19 |
TIE-2 ligands, methods of making and uses thereof App 20050100906 - Davis, Samuel ;   et al. | 2005-05-12 |
Methods of modifying genes in eukaryotic cells App 20050003543 - Economides, Aris N. ;   et al. | 2005-01-06 |
Expressed ligand--vascular intercellular signalling molecule Grant 6,825,008 - Davis , et al. November 30, 2 | 2004-11-30 |
Biologically active Eph family ligands App 20030215918 - Davis, Samuel ;   et al. | 2003-11-20 |
Method of blocking blood vessel growth using tie-2 ligand 2 Grant 6,645,484 - Davis , et al. November 11, 2 | 2003-11-11 |
TIE-2 ligands, methods of making and uses thereof Grant 6,627,415 - Davis , et al. September 30, 2 | 2003-09-30 |
TIE-2 ligands, methods of making and uses thereof App 20030166858 - Davis, Samuel ;   et al. | 2003-09-04 |
TIE-2 ligands, methods of making and uses thereof App 20030166857 - Davis, Samuel ;   et al. | 2003-09-04 |
Biologically active Eph family ligands Grant 6,602,683 - Davis , et al. August 5, 2 | 2003-08-05 |
TIE-2 ligands, methods of making and uses thereof App 20030109677 - Davis, Samuel ;   et al. | 2003-06-12 |
Expressed ligand - vascular intercellular signalling molecule App 20030092891 - Davis, Samuel ;   et al. | 2003-05-15 |
TIE-2 ligands, methods of making and uses thereof App 20020173627 - Davis, Samuel ;   et al. | 2002-11-21 |
Expressed ligand-vascular intercellular signalling molecule Grant 6,441,137 - Davis , et al. August 27, 2 | 2002-08-27 |
Tie-2 ligands Grant 6,433,143 - Davis , et al. August 13, 2 | 2002-08-13 |
Expressed ligand-vascular intercellular signalling molecule Grant 6,265,564 - Davis , et al. July 24, 2 | 2001-07-24 |
Antibodies to human TIE-2 ligands Grant 6,166,185 - Davis , et al. December 26, 2 | 2000-12-26 |
Tie-2 ligand 1 Grant 5,879,672 - Davis , et al. March 9, 1 | 1999-03-09 |
Nucleic acids encoding TIE-2 ligand-2 Grant 5,814,464 - Davis , et al. September 29, 1 | 1998-09-29 |
Method of enhancing the biological activity of Eph family ligands Grant 5,747,033 - Davis , et al. May 5, 1 | 1998-05-05 |
Tie-2 ligand 2 Grant 5,650,490 - Davis , et al. July 22, 1 | 1997-07-22 |
Nucleic acid encoding tie-2 ligand Grant 5,643,755 - Davis , et al. July 1, 1 | 1997-07-01 |
TIE-2 ligand, and method of making Grant 5,521,073 - Davis , et al. May 28, 1 | 1996-05-28 |
Mammalian expression vector Grant 5,266,490 - Davis , et al. November 30, 1 | 1993-11-30 |
SEC | 0001046891 | DAVIS SAMUEL |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.